Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease
Neurobiology of Disease · 2025
DOI: 10.1016/j.nbd.2024.106780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Hui Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, …. Hauptthemen laut MEDLINE: Huntington Disease, Huntingtin Protein, Retina, Retinal Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, NINDS NIH HHS, Cure Huntington's Disease Initiative.
Abstract (Originalsprache)
Huntington's disease (HD) is caused by the expansion of a CAG repeat, encoding a string of glutamines (polyQ) in the first exon of the huntingtin gene (HTTex1). This mutant huntingtin protein (mHTT) with extended polyQ forms aggregates in cortical and striatal neurons, causing cell damage and death. The retina is part of the central nervous system (CNS), and visual deficits and structural abnormalities in the retina of HD patients have been observed. Defects in retinal structure and function are also present in the R6/2 and R6/1 HD transgenic mouse models that contain a gene fragment to express mHTTex1. We investigated whether these defects extend to the zQ175KI mouse model which is thought to be more representative of the human condition because it was engineered to contain the extended CAG repeat within the endogenous HTT locus. We found qualitatively similar phenotypes between R6/1 and zQ175KI retinae that include the presence of mHTT aggregates in retinal neurons, cone loss, downregulation of rod signaling proteins and abnormally elongated photoreceptor connecting cilia. In addition, we present novel findings that mHTT disrupts cell polarity in the photoreceptor cell layer and the retinal pigment epithelium (RPE). Furthermore, we show that the RPE cells from R6/1 mice contain mHTT nuclear inclusions, adding to the list of non-neuronal cells with mHTT aggregates and pathology. Thus, the eye may serve as a useful system to track disease progression and to test therapeutic intervention strategies for HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology & Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Department of Physiology & Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: jeannie@usc.edu.
Förderung
- NEI NIH HHS
- NINDS NIH HHS
- Cure Huntington's Disease Initiative
- NINDS
Zitieren
APA
Xu, H., Ajayan, A., Langen, R., & Chen, J. (2025). Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106780
Vancouver
Xu H, Ajayan A, Langen R, Chen J. Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2024.106780
BibTeX
@article{Xu2025,
author = {Xu, Hui and Ajayan, Anakha and Langen, Ralf and Chen, Jeannie},
title = {Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease},
journal = {Neurobiology of Disease},
year = {2025},
doi = {10.1016/j.nbd.2024.106780}
}
EUVIMED